Alzheimer's disease (AD) is the most common form of dementia and results in neurodegeneration and cognitive impairment. White matter (WM) is affected in AD and has implications for neural circuitry and cognitive function. The trajectory of these changes across age, however, is still not well understood, especially at earlier stages in life. To address this, we used theAppNL∼G∼F/NL∼G∼Fknock-in (APPKI) mouse model that harbors a single copy knock-in of the human amyloid precursor protein (App) gene with three familial AD mutations. We performedin vivodiffusion tensor imaging (DTI) to study how the structural properties of the brain change across age in the context of AD. In late age APPKI mice, we observed reduced fractional anisotropy (FA), a proxy of WM integrity, in multiple brain regions, including the hippocampus, anterior commissure, neocortex, and hypothalamus. At the cellular level, we observed greater numbers of oligodendrocytes in middle age (prior to observations in DTI) in both the anterior commissure, a major interhemispheric WM tract, and the hippocampus, which is involved in memory and heavily affected in AD, prior to observations in DTI. Proteomics analysis of the hippocampus also revealed altered expression of oligodendrocyte-related proteins with age and in APPKI mice. Together, these results help to improve our understanding of the development of AD pathology with age, and imply that middle age may be an important temporal window for potential therapeutic intervention.Significance StatementAlzheimer's disease (AD) is a progressive neurodegenerative disorder that develops decades before onset of cognitive impairment. The trajectory of the pathology across age in white matter (WM), however, is still not well understood. Here, we used anAppNL∼G∼F/NL∼G∼Fknock-in mouse model to study WM using DTI and biochemical analyses. We observed reduced FA, a WM integrity proxy, in the hippocampus and anterior commissure between middle and late age. Notably, we observed changes in oligodendrocytes in middle age that preceded the changes in DTI. Together, this suggests that alterations in oligodendrocyte homeostasis may contribute to changes in WM in middle age. These results may serve as an important biomarker, therapeutic target, and provide new insight into the progression of AD.